DEBT - Narrative (Details)
|
|
1 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
|
|
|
Dec. 31, 2022
USD ($)
|
Apr. 30, 2023
USD ($)
|
Dec. 31, 2022
USD ($)
|
Nov. 30, 2022
USD ($)
shares
|
Sep. 30, 2022 |
Jul. 31, 2022
USD ($)
|
Apr. 30, 2022
USD ($)
|
Mar. 31, 2022
USD ($)
month
note
|
Oct. 31, 2021
USD ($)
|
Sep. 30, 2021
USD ($)
|
Dec. 31, 2023
USD ($)
debtInstrument
loan
$ / shares
shares
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
Feb. 06, 2024
USD ($)
$ / shares
|
Jan. 01, 2024
USD ($)
|
Nov. 30, 2023
USD ($)
|
Nov. 10, 2023 |
Sep. 01, 2023
USD ($)
$ / shares
shares
|
Jun. 30, 2023
USD ($)
$ / shares
|
May 31, 2023
$ / shares
|
Mar. 31, 2023
USD ($)
|
Mar. 15, 2023
USD ($)
|
Jan. 31, 2023
USD ($)
|
Apr. 30, 2021
USD ($)
|
Jan. 31, 2021
USD ($)
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, contingent debt, not subject to repayment terms | debtInstrument |
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt |
$ 206,357,000
|
|
$ 206,357,000
|
|
|
|
|
|
|
|
$ 225,592,000
|
$ 206,357,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash bonus forfeited for alternative payment method |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 750,000
|
|
|
|
|
Annual cash bonus |
|
|
|
|
|
|
|
|
|
|
850,000
|
|
|
|
|
$ 213,000
|
|
|
|
|
|
$ 250,000
|
|
|
|
Redemptions of senior notes |
|
|
|
|
|
|
|
|
|
|
0
|
33,726,000
|
$ 8,134,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Losses on debt redemptions/extinguishments/modifications |
|
|
|
|
|
|
|
|
|
|
0
|
(18,858,000)
|
(3,815,000)
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from long-term lines of credit |
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ 25,000,000
|
40,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible debt |
|
|
|
$ 2,412,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,562,000
|
Number of mortgage loans | loan |
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsequent Event |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative warrants exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.00
|
|
|
|
|
|
|
|
|
|
|
|
Increase in annual base salary |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
Super Voting Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued upon conversion of debt at maturity (in shares) | shares |
|
|
|
910,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NuLeaf |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument term |
|
|
|
|
|
5 years
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment for contingent consideration liability |
|
|
|
|
|
$ 3,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nature’s Remedy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment for contingent consideration liability |
|
|
|
|
|
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
17,512,280
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, term |
|
|
|
|
|
|
|
|
|
|
4 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount on warrant |
|
|
|
|
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Warrants to Purchase Super Voting Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative warrants exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.80
|
|
|
|
|
|
|
$ 0.68
|
$ 1.00
|
$ 2.086
|
|
|
|
|
|
Value of securities called by warrants or rights |
|
|
|
|
|
|
|
|
|
|
$ 575,000
|
|
|
|
|
|
|
|
|
|
|
375,000
|
|
|
|
Derivative warrants exercises (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
718,750
|
|
|
|
|
|
|
551,471
|
|
|
|
|
|
|
|
Warrants and rights outstanding |
|
|
|
|
|
|
|
|
|
|
$ 191,000
|
|
|
|
|
|
|
$ 200,000
|
|
|
|
|
|
|
|
Debt instrument, unamortized discount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,341,000
|
|
|
|
|
|
|
Unsecured Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
12.00%
|
|
12.00%
|
|
|
|
|
|
|
|
|
12.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Senior Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Promissory notes payable to Sammartino | Notes payable, other payables |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
$ 16,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2026 |
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt |
$ 21,500,000
|
|
$ 21,500,000
|
|
|
|
|
|
|
|
21,500,000
|
$ 21,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jushi Europe debt | Other debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt |
3,189,000
|
|
3,189,000
|
|
|
|
|
|
|
|
3,298,000
|
3,189,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Second Lien Notes | Unsecured Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2026 |
|
|
|
|
|
|
|
|
|
|
75,497,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt |
73,182,000
|
|
73,182,000
|
|
|
|
|
|
|
|
75,497,000
|
73,182,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument principal amount |
73,061,000
|
|
73,061,000
|
|
|
|
|
|
|
|
1,150,000
|
73,061,000
|
|
|
|
|
|
|
|
|
|
$ 750,000
|
|
|
|
Proceeds from issuance of unsecured debt |
|
|
31,594,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repurchase amount |
41,467,000
|
|
41,467,000
|
|
|
|
|
|
|
|
|
41,467,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.00%
|
|
|
|
|
Second Lien Notes | Unsecured Debt | Subsequent Event |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,750,000
|
|
|
|
|
|
|
|
|
|
|
|
Senior Notes Due January 15, 2023 | Senior Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Senior notes, current |
$ 74,935,000
|
|
74,935,000
|
|
|
|
|
|
|
|
|
$ 74,935,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redemptions of senior notes |
|
|
33,468,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayments of senior debt, noncash |
|
|
41,467,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Losses on debt redemptions/extinguishments/modifications |
|
|
$ 18,858,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition Facility | Senior Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument principal amount |
|
|
|
|
|
|
|
|
$ 100,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unused capacity, commitment fee percentage |
|
|
|
|
|
|
|
|
2.25%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitment fee percentage upon maturity or refinancing |
|
|
|
|
|
|
|
|
1.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Early repayment of debt, fee percentage |
|
|
|
|
|
|
|
|
1.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Right of first refusal, percentage |
|
|
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition Facility | Acquisition Facility | Secured Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
11.00%
|
|
11.00%
|
|
|
|
|
|
9.50%
|
|
|
11.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, unamortized discount |
$ 4,363,000
|
|
$ 4,363,000
|
|
|
|
|
|
$ 1,701,000
|
|
2,169,000
|
$ 4,363,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit facility, maximum borrowing capacity |
65,000,000
|
|
65,000,000
|
|
|
|
|
|
$ 100,000,000
|
|
|
65,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument term |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit facility, draw period |
|
|
|
|
|
|
|
|
18 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, interest rate, term |
|
|
|
|
|
|
|
|
2 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accordion feature, higher borrowing capacity option |
|
|
|
|
|
|
|
|
$ 25,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt issuance costs |
|
|
|
|
|
|
|
|
721,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from long-term lines of credit |
|
|
|
|
|
|
$ 25,000,000
|
|
$ 40,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining borrowing capacity |
60,000,000
|
|
60,000,000
|
|
|
|
|
|
|
|
|
60,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Periodic payment |
|
|
|
|
|
|
|
|
|
|
2,438,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balloon payment to be paid |
|
|
|
|
|
|
|
|
|
|
50,375,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition Facility | Acquisition Facility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
60,125,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2026 |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt |
|
|
|
|
|
|
|
|
|
|
60,125,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of outstanding term loans |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
Acquisition Facility | Acquisition Facility | Revolving Credit Facility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt |
65,000,000
|
|
$ 65,000,000
|
|
|
|
|
|
|
|
$ 60,125,000
|
$ 65,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OSD Notes Due April 30, 2027 | Secured Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,100,000
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.00%
|
|
Apothecarium Notes Due March 16, 2027 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of debt instruments | note |
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Apothecarium Notes Due March 16, 2027 | Unsecured Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument principal amount |
|
|
|
|
|
|
|
$ 9,853,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Periodic payment, principal |
|
|
|
|
|
|
|
$ 3,448,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Periodic payment, period | month |
|
|
|
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining balance monthly installments, term | month |
|
|
|
|
|
|
|
39
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nuleaf Unsecured Promissory Notes | Unsecured Debt | NuLeaf |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument principal amount |
|
|
|
|
|
|
$ 15,750,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NuLeaf Five-Year Note | NuLeaf |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument term |
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nature's Remedy Three-Year Note | Nature’s Remedy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument term |
|
|
|
|
3 years
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nature's Remedy Three-Year Note | Unsecured Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument principal amount |
|
|
|
|
|
|
|
|
|
$ 11,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument term |
|
|
|
|
3 years
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nature's Remedy Five-Year Note |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument term |
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nature's Remedy Five-Year Note | Nature’s Remedy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument term |
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nature's Remedy Five-Year Note | Unsecured Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument principal amount |
|
|
|
|
|
|
|
|
|
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Arlington Mortgage | Mortgages |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
|
5.875%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit facility, maximum borrowing capacity |
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from long-term lines of credit |
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining borrowing capacity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,900,000
|
|
|
Credit Facility Maturing July 18, 2027 | Acquisition Facility | Revolving Credit Facility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
|
10.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit facility, maximum borrowing capacity |
|
|
|
|
|
$ 2,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Facility Maturing July 18, 2027 | Acquisition Facility | Revolving Credit Facility | Prime Rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument basis spread on variable rate |
|
|
|
|
|
|
|
|
|
|
2.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Manassas Mortgage | SOFR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument basis spread on variable rate |
|
3.55%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Manassas Mortgage | Mortgages |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument principal amount |
|
$ 20,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument interest rate |
|
|
|
|
|
|
|
|
|
|
9.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Floor rate |
|
8.25%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|